Cargando…
EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
Autores principales: | TOUMAN, A., BULKHI, A., AL-QURASHI, E., GHALIB, N., ALDOBYANY, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212609/ http://dx.doi.org/10.1016/j.chest.2021.12.286 |
Ejemplares similares
-
FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020) -
PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022) -
A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021) -
MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022) -
COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)